This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 598065
Submitted by lobbyist on: November 9, 2016 12:05:26 PM
Accepted by Registrar on: November 9, 2016 12:27:01 PM
Designated Filer Information
| Lanman, Lydia |
| 3650 Danforth Avenue | |
|
Toronto, ON, M1N 2E8
|
587-337-4043 |
| Canada |
Organization Information
| Eli Lilly Canada Inc. |
| Eli Lilly is committed to providing answers that matter in medicine, life sciences and health care. As a leading inovation-driven pharmaceutical corporation, Lilly is developing a growing portfolio of products by applying the latest research from its own worldwide laboratories, by collaborating with eminent scientific organizations, by making use of the most up-to-date technological tools and by providing exceptional service to its customers. Headquartered in Indianapolis, Indiana, Lilly provides answers; through medicines and information; for some of the world's most urgent medical needs. Eli Lilly Canada, headquartered in Toronto, Ontario, employs more than 500 people across the country. Additional information about Eli Lilly Canada can be found at www.lilly.ca. |
| 3650 Danforth Avenue | |
|
Toronto, ON, M1N 2E8
|
587-337-4043 |
| Canada |
Relevant Affiliates
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| November 9, 2016 | |
| May 8, 2017 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Policy discussions related to pharmaceutical pricing, pan-Canadian Pharmaceutical Alliance (pCPA) initiatives, public drug plan design, health system design, and Alzheimer's disease.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Ashton, Dan | Parliamentary Secretary for the Minister of Finance | November 9, 2016 |
| Minister | Clark, Christy | Premier | November 9, 2016 |
| Minister | Lake, Terry | Minister of Health | November 9, 2016 |
| Minister | Plecas, Darryl | Parliamentary Secretary for Seniors to the Minister of Health | November 9, 2016 |
| Minister | Stilwell, Michelle | Minister of Social Development and Social Innovation | November 9, 2016 |
| Public Agency | Health | November 9, 2016 |
Intellectual Property
Development, establishment, amendment or termination of any program, policy or decision
Policy discussions related to the importance of intellectual property protection and patent utility.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Ashton, Dan | Parliamentary Secretary for the Minister of Finance | November 9, 2016 |
| Minister | Clark, Christy | Premier | November 9, 2016 |
| Minister | Lake, Terry | Minister of Health | November 9, 2016 |
| Minister | Virk, Amrik | Minister of Technology, Innovation and Citizens' Services | November 9, 2016 |
| Minister | Wat, Teresa | Minister of International Trade | November 9, 2016 |
| Minister | Wilkinson, Andrew | Minister of Advanced Education | November 9, 2016 |
Science and Technology
Development, establishment, amendment or termination of any program, policy or decision
Policy discussions related to pharmaceutical innovation, research and development, and Lilly's approach to global partnering and investment.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Ashton, Dan | Parliamentary Secretary for the Minister of Finance | November 9, 2016 |
| Minister | Bond, Shirley | Minister of Jobs, Tourism and Skills Training | November 9, 2016 |
| Minister | Clark, Christy | Premier | November 9, 2016 |
| Minister | de Jong, Mike | Minister of Finance | November 9, 2016 |
| Minister | Lake, Terry | Minister of Health | November 9, 2016 |
| Minister | Virk, Amrik | Minister of Technology, Innovation and Citizens' Services | November 9, 2016 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Discussions related to Lilly's products in the following therapeutic areas for the purpose of maintaining and/or obtaining public reimbursement: diabetes, depression, chronic pain, psoriasis, rheumatoid arthritis, pediatric growth hormone deficiency, lung cancer, colorectal cancer, gastric cancer, soft tissue sarcoma, Alzheimer's disease.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Fraser Health Authority | November 9, 2016 | |
| Public Agency | Health | November 9, 2016 | |
| Public Agency | Interior Health Authority | November 9, 2016 | |
| Public Agency | Providence Health Care Society | November 9, 2016 | |
| Public Agency | Provincial Health Services Authority | November 9, 2016 | |
| Public Agency | Vancouver Coastal Health Authority | November 9, 2016 | |
| Public Agency | Vancouver Island Health Authority | November 9, 2016 |